D.Western Therapeutics Institute, Inc.

4576

TSE PrimePharmaceuticals

¥ -

You can review earnings summary, quarterly trends, full-year progress, and detailed income statement data.

descriptionIncome Statement (PL) Summary

Updated: 2026-08-13FY2026 Q2

Revenue

2.5100M JPY

YoY -41.2%

Operating Income

-3.1100M JPY

YoY -1.3%

Net Income

-6.4100M JPY

YoY +41.2%

EPS

-5.8JPY

YoY +18.1%

Performance Trend

Revenue, operating income and net income trend (last 5 periods)

RevenueOperatingNet Income

4.7億円

31.1百万円

-4.1億円

-8.5億円

-12.9億円

Rev: 4.1億円Op: -1.7億円NI: -1.5億円

Rev: 4.5億円Op: -3.1億円NI: -4.3億円

Rev: 4.3億円Op: -8億円NI: -8.1億円

Rev: 4.7億円Op: -12.1億円NI: -12.9億円

Rev: 3.9億円Op: -6.2億円NI: -6.3億円

2021/FY2022/FY2023/FY2024/FY2025/FY

Full-Year Progress

FY2026 Q2

Net Income40.4%

Revenue Progress33.1M

Revenue Forecast300M

Net Income Progress-3.200M

Net Income Forecast-800M

Income Statement Details

Unit: JPY

Unlock Long-Term Financial Data

Your current plan allows viewing financial data for the latest 1 year (annual only). Upgrade to the Standard Plan to view up to 3 years (including quarterly data), or the Premium Plan to access all historical data.

Standard Plan Premium Plan